Price Alert

Tempest Therapeutics Inc. (TPST)

NASDAQ: TPST · Real-Time Price · USD

10.58

1.10 (11.60%)

At close: Aug 15, 2025, 3:59 PM

10.72

1.32%

After-hours: Aug 15, 2025, 07:28 PM EDT

Tempest Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	14.28M	21.51M	30.27M	22.12M	31.12M	32.33M	39.23M	11.12M	17.6M	22.93M	31.23M	42.79M	51.62M	45.75M	51.83M	59.72M	68.41M	26.85M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	439K
Long-Term Investments	388K	388K	388K	388K	n/a	388K	388K	388K	368K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	141K	150K	97K	60K	448K	60K	60K	5K	30K	429K	429K	683K	480K	480K	111K	112K	112K	299K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	342K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	908K	1.26M	n/a	n/a	1.05M	n/a
Other Current Assets	823K	922K	535K	385K	152K	586K	96K	232K	639K	1.15M	713K	16.14M	16.38M	16.31M	15.55M	1.54M	731K	n/a
Total Current Assets	15.1M	22.43M	31.47M	23.55M	31.55M	33.5M	40.36M	12.29M	18.54M	24.67M	32.95M	60.26M	68.31M	62.71M	68.96M	62.56M	70.49M	29.39M
Property-Plant & Equipment	8.85M	9.19M	9.53M	9.84M	10.17M	10.43M	10.79M	11.3M	11.81M	12.23M	12.71M	2.23M	2.56M	3.76M	4.16M	4.47M	4.89M	2.01M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	9.38M	9.73M	10.01M	10.28M	10.62M	10.88M	11.24M	11.7M	12.21M	12.66M	13.14M	2.91M	3.04M	4.24M	4.28M	4.58M	5M	2.31M
Total Assets	24.48M	32.16M	41.49M	33.84M	42.17M	44.38M	51.6M	23.99M	30.74M	37.33M	46.09M	63.17M	71.35M	66.95M	73.24M	67.14M	75.5M	31.71M
Account Payables	4.72M	2.19M	2.45M	1.7M	1.36M	1.05M	845K	1.14M	868K	1.16M	1.11M	925K	1.45M	684K	991K	2.38M	6.7M	811K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.1M	4.19M	6.35M	8.5M	8.64M	6.46M	4.29M	2.13M	2.97M	1.48M	n/a	3.5M	2M	n/a	n/a	n/a	n/a	977K
Other Current Liabilities	1.22M	n/a	n/a	1.4M	1.55M	n/a	834K	984K	1.15M	450K	450K	14.33M	13.95M	13.53M	15M	n/a	n/a	1.37M
Total Current Liabilities	7.14M	13.18M	14.22M	13.97M	14.56M	10.69M	9.41M	7.42M	8.64M	7.51M	7.28M	24.06M	22.42M	20.82M	20.03M	6.2M	9.79M	4.6M
Long-Term Debt	7.56M	7.85M	n/a	8.41M	2.01M	4.14M	6.26M	8.37M	7.48M	8.94M	10.37M	11.84M	13.3M	15.13M	15.07M	15.01M	14.91M	1.48M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.48M
Total Long-Term Liabilities	7.56M	7.85M	8.14M	8.41M	10.67M	13.05M	15.42M	17.75M	17.09M	18.85M	20.7M	12.34M	14M	16.78M	17.09M	17.4M	17.59M	1.48M
Total Liabilities	14.7M	21.03M	22.36M	22.38M	25.23M	23.75M	24.84M	25.18M	25.73M	26.36M	27.98M	36.4M	36.42M	37.6M	37.12M	23.61M	27.38M	6.08M
Total Debt	8.66M	13.11M	15.37M	17.74M	20.25M	20.37M	20.66M	21.01M	21.48M	21.66M	22.11M	16.71M	17.05M	18.25M	18.54M	18.81M	19.07M	2.46M
Common Stock	4K	4K	44K	27K	24K	22K	22K	14K	13K	11K	11K	10K	10K	7K	7K	7K	7K	19K
Retained Earnings	-225.84M	-217.97M	-207.11M	-193.29M	-182.74M	-173.17M	-165.26M	-157.78M	-150.99M	-143.41M	-135.77M	-126.67M	-117.72M	-108.55M	-100.06M	-92.28M	-84.17M	-253.45M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-89K	-75.5M	277K
Shareholders Equity	9.78M	11.13M	19.13M	11.46M	16.94M	20.63M	26.77M	-1.19M	5.01M	10.96M	18.11M	26.77M	34.93M	29.36M	36.12M	43.54M	48.11M	24.96M
Total Investments	388K	388K	388K	388K	388K	388K	388K	388K	368K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	439K